| # | Drug | Count |
|---|---|---|
| 0 | INSULIN GLARGINE | 11 |
| 1 | INSULIN GLARGINE-YFGN | 10 |
| 2 | ADALIMUMAB | 9 |
| 3 | ADALIMUMAB-AATY | 9 |
| 4 | ADALIMUMAB-ADAZ | 9 |
| 5 | ADALIMUMAB-FKJP | 9 |
| 6 | BEZLOTOXUMAB | 9 |
| 7 | VANCOMYCIN HYDROCHLORIDE | 9 |
| 8 | VANCOMYCIN | 8 |
| 9 | METFORMIN | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BEZLOTOXUMAB | 9 | 0.0257 |
| 1 | ERTUGLIFLOZIN AND SITAGLIPTIN | 1 | 0.0083 |
| 2 | CALCIFEDIOL | 4 | 0.0016 |
| 3 | VANCOMYCIN HYDROCHLORIDE | 9 | 0.0011 |
| 4 | PASIREOTIDE | 2 | 0.0009 |
| 5 | INSULIN DEGLUDEC AND LIRAGLUTIDE | 1 | 0.0006 |
| 6 | ESTAZOLAM | 1 | 0.0005 |
| 7 | INSULIN GLARGINE-YFGN | 10 | 0.0004 |
| 8 | TEDUGLUTIDE | 4 | 0.0003 |
| 9 | ASCORBIC ACID | 5 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 16 |
| 1 | Insulin Analog [EPC] | 12 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 10 |
| 3 | Glycopeptide Antibacterial [EPC] | 9 |
| 4 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 6 |
| 5 | Benzodiazepine [EPC] | 5 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 5 |
| 7 | Vitamin C [EPC] | 5 |
| 8 | Alkylating Drug [EPC] | 4 |
| 9 | Aromatase Inhibitor [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | GLP-2 Analog [EPC] | 4 | 0.0003 |
| 1 | Somatostatin Analog [EPC] | 2 | 0.0003 |
| 2 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 1 | 0.0002 |
| 3 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 4 | Glycopeptide Antibacterial [EPC] | 9 | 0.0001 |
| 5 | PCSK9 Inhibitor [EPC] | 2 | 0.0001 |
| 6 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 2 | 0.0001 |
| 7 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 6 | 0.0001 |
| 8 | Programmed Death Ligand-1 Blocker [EPC] | 1 | 0.0000 |
| 9 | Erythropoiesis-stimulating Agent [EPC] | 2 | 0.0000 |